Description
A CCR2 antagonist (IC50s = 5.2, 13, and 17 nM for the human, rat, and mouse receptors, respectively); inhibits the voltage-gated potassium channel subtype Kv11.1 by 35% at 10 µM; decreases CCL2 induced chemotaxis of isolated human monocytes (IC50 = 3.9 nM)
Formal name: N-[2-[(3S)-3-[[trans-4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]cyclohexyl]amino]-1-pyrrolidinyl]-2-oxoethyl]-3-(trifluoromethyl)-benzamide
Synonyms: INCB 8761
Molecular weight: 568.6
CAS: 1341224-83-6
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Ion Channel Modulation|Blockers||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Immunology & Inflammation|Innate Immunity